Rings 50 New Jobs To The Area Quot There Is An Increasing Demand For Hpapis Due Their Effectiveness Against Cancer At Lower Doses And Trend Towards More Targeted Therapeutics Of These Therapies Reduce Negative Side Effects Patients Who Are Taking On This Critical Fight News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry's largest manufacturers of these components globally Builds on company's 30 years' CDMO experience with multi-step, complex, and highly potent compounds DARMSTADT, Germany, June 23, 2022 /PRNewswire/ Merck, a leading science and technology company, announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of its facility in Verona, near Madison, Wisconsin, USA. This new 59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area. "There is an increasing demand for HPAPIs due to their effectiveness against cancer at lower doses and the trend towards more targeted therapeutics. Lower-doses of these therapies reduce the negative side effects for patients who are taking on this critical fight," said Dirk Lange, ....

United States , Prnewswire Merck , Dirk Lange , Merck Verona , Life Science Services , Life Science , North America , Cancer Facts , Expansion Doubles Production Of The Most Highly Potent Active Pharmaceutical Ingredients Hpapis Merck Now One Industry 39s Largest Manufacturers These Components Globally Builds On Company 30 Years 39 Cdmo Experience With Multi Step , Nd Highly Potent Compounds Darmstadt , June 23 , 022 Prnewswire Merck , A Leading Science And Technology Company , Nnounced That Its Life Science Business Sector Has Doubled High Potent Active Pharmaceutical Ingredients Hpapi Production Capacity With The Expansion Of Facility In Verona , Year Madison , Sa This New 59 Million , 0000 Square Foot Facility , Fficially Opened Today , Rings 50 New Jobs To The Area Quot There Is An Increasing Demand For Hpapis Due Their Effectiveness Against Cancer At Lower Doses And Trend Towards More Targeted Therapeutics Of These Therapies Reduce Negative Side Effects Patients Who Are Taking On This Critical Fight , Uot Said Dirk Lange , Head Of Life Science Services , Life Science , T Merck Quot Increasing Capacity At Our State Of The Art Cdmo Facility In Verona , Isconsin Will Allow Us To Meet The Need For These Key Cancer Treatment Components Quot Is Second Leading Cause Of Death Worldwide1 Hpapis Area Critical Element Targeted Therapies Due Their Extremely Effective Cell Killing Abilities At Low Doses , Esulting In Reduced Side Effects For Patients They Are Used Novel Cancer Therapies , Ncluding Antibody Drug Conjugates Adcs ,